Private Equity Investments In European Healthcare Tumble H2’22

Published on

Global private equity investment in the European healthcare industry fell by more than a quarter in 2022, with the second half of the year seeing a particularly sluggish performance, according to S&P Global Market Intelligence analysis.

The aggregate transaction value for private equity investments in the space came to $18.88 billion across 813 deals in 2022, compared to $25.79 billion from 983 deals a year earlier, according to S&P Global Market Intelligence data.

Get The Full Henry Singleton Series in PDF

Get the entire 4-part series on Henry Singleton in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues

Q4 2022 hedge fund letters, conferences and more


Key Highlights

  • Deal volume for all of 2022 ended up peaking in the first quarter, with 234 transactions bringing in $7.50 billion. In the final three months of the year, investments were down by more than half at $3.28 billion.
  • Healthcare services received the greatest investment, with private equity pouring in $7.01 billion, followed by pharmaceuticals at $3.97 billion and biotechnology at $2.93 billion. The three subsectors accounted for more than 70% of the total private equity investments in European healthcare.

Largest Deals


European Healthcare

European Healthcare

European Healthcare

European Healthcare